Web10 okt. 2024 · About Ionis Pharmaceuticals, Inc. As the leader in RNA-targeted drug discovery and development, Ionis has created an efficient, broadly applicable, proprietary antisense technology platform with the potential to treat diseases where no other therapeutic approaches have proven effective. WebFor more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with our novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises.
Ionis strengthens leadership team with appointments of Joseph …
WebIonis has helped Biogen understand our antisense platform and the large potential of this powerful drug modality in neurological diseases,” said Dr. C. Frank Bennett, senior vice … WebÉtudiant en première année de M1 Biotechnologies et Management à l'école de la double compétence Ionis-STM, j'ai pour objectif d'accroître mes connaissances dans le domaine du Management et du Marketing, à la suite de la validation de ma licence Sciences de la Vie, afin d'enrichir mon panel de compétences. Durant ma formation en … european single serve coffee makers rate
IONIS Leadership Development & Coaching Introduction by Lead …
Web9 mei 2024 · Publisher: IONIS Whole Person Leadership Coaching & Development Total Episodes : 7 IONIS Whole Person Leadership Development and Coaching presents the Leader Manager series.Tips and Tricks focused on developing the leadership skills you need for developing yourself, your employees and teams. ~ We believe your success … Web5 mei 2024 · The Ionis founder and CEO spent decades fighting to turn antisense oligonucleotides into drugs; now that they're finally living up to the promise, he's stepping … Webvan der Beelen, PhD. Scientist. Head of Liposome Technology. Vice President and Head of mRNA R&D. Senior Scientist, Oligonucleotide Development. Zieler, PhD. Founder & President. european sister brand of buick